Humacyte Inc (HUMA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $155.12M
Last updated: Nov 17, 2026 at 4:28 PM ET
Humacyte Inc (HUMA) Stock Chart
Humacyte (HUMA) has a latest price of $0.50 on Nov 17, 2026, 67.1% below its 52-week high of $1.52. Its price fell 59.3% over the past 12 months. The month-end price fell 95.5% over the 5 years through Oct 2026, a compound annual decline of 46.2%.
Price Chart
From Aug 2021 to Oct 2026, its highest month-end close was $14.62 in Aug 2021 and its lowest $0.41 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart HUMA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for HUMA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 31.8%, and over 6 months it fell 39.3%. The month-end price fell 80.6% over the 3 years through Oct 2026, a compound annual decline of 42.1%.
| Period | Change |
|---|---|
| 1 month | +24.9% |
| 3 months | -31.8% |
| 6 months | -39.3% |
| 12 months | -59.3% |
| 12 months, with dividends | -59.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -80.6% | -42.1% |
| 5 years | -95.5% | -46.2% |
Price by Year
Its best calendar year was 2024, when the price rose 77.8%, and its weakest was 2025, when it fell 81.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.41 | -57.2% |
| 2025 | $0.96 | -81.0% |
| 2024 | $5.05 | +77.8% |
| 2023 | $2.84 | +34.6% |
| 2022 | $2.11 | -70.9% |
Trading Range
The price is 2.1% above its 50-day average of $0.49 and 35.3% below its 200-day average of $0.77.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.50 | |
| 52-week high | $1.52 | -67.1% |
| 52-week low | $0.34 | +48.7% |
| 50-day average | $0.49 | +2.1% |
| 200-day average | $0.77 | -35.3% |
Price Risk
Over 3 years, its largest fall from a peak was 96.3%.
| Measure | Value |
|---|---|
| 1-year beta | 2.67 |
| Largest fall, 1 year | -76.2% |
| Largest fall, 3 years | -96.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About HUMA
What is HUMA's 1-year price change?
Humacyte's price fell 59.3% over the past 12 months. With dividends included, the 12-month total return was -59.3%.
What is HUMA's 5-year price change?
Humacyte's month-end price fell 95.5% over the 5 years through Oct 2026, a compound annual decline of 46.2%. These figures leave out dividends.
What is HUMA's 52-week high and low?
Humacyte's 52-week high is $1.52 and its 52-week low is $0.34. Its latest price of $0.50 on Nov 17, 2026 is 67.1% below the high.
What is HUMA's beta?
Humacyte's 1-year beta against the S&P 500 is 2.67, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 76.2%.
Is the HUMA chart free?
Yes. Advanced Charting for HUMA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
HUMA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors